Neurotoxicity of PBDEs on the Developing Nervous System by Banasik, Marek & Suchecka, Dominika
Correspondence
Environmental Health Perspectives  •  v o l u m e 119 | number 8 | August 2011  A 331
and are uncertain about why community 
members are dying from what appear to the 
survivors to be unusual causes. Although 
Hrudey may feel this concern is misplaced or 
unfounded, that opinion does not reflect the 
feelings of those who live in Fort Chipewyan. 
The Alberta government’s assertion that 
more extensive health studies are warranted 
(Chen 2009) and stated intention to actively 
pursue such studies (Weinhold 2011) suggest 
adverse health effects are at least plausible. 
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Dingemans et al. (2011) published a review 
article on polybrominated diphenyl ethers 
(PBDEs) and the developing nervous system. 
However, the authors summarized but failed 
to criti  cally evaluate the articles cited in their 
review. They also did not discuss or cite litera-
ture that contradicted the studies on which 
they based their conclusions. For example, 
the U.S. Environmental Protection Agency 
(EPA) cosponsored an expert panel on neuro-
develop  mental end points, which concluded 
that an experimental design used in nine of 
the studies cited by Dingemans et al. (2011) 
failed to control for litter effects (Holson et al. 
2008). 
Although some investigators have set 
forth the argument that direct dosing of 
pups precludes the need to control for litter 
effects, a U.S. EPA cosponsored expert panel 
(Moser et al. 2005) evaluated this issue and 
concluded otherwise. 
Regardless of whether Dingemans et al. 
(2011) view the studies by Holson et al. 
(2008) and Moser et al. (2005) as cred-
ible, the authors should have discussed them 
to some degree. It is understandable that 
because of space limitations not all studies 
can be included in a review. However, it was 
unacceptable to exclude studies that carry 
the weight of U.S. EPA cosponsored expert 
panels or other reviews that critically evalu-
ated many of the studies cited by Dingemans 
et al. (2011) (e.g., Goodman 2009; Hardy 
et al. 2009; Williams and DeSesso 2010) 
and came to opposite conclusions. 
Although the article by Dingemans et al. 
(2011) was peer-reviewed, it presents informa-
tion in a selective, noncritical manner, which 
is best reserved for public relation pieces com-
municated in the non–peer-reviewed media. 
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Banasik and Suchecka express their discon-
tent with our recent review on the (in-)direct 
neurotoxic effects of parent and hydrox  ylated 
(OH-) polybrominated diphenyl ethers 
(PBDEs) on the (developing) nervous sys-
tem (Dingemans et al. 2011). Their main 
discontent appears to be once more related 
to the experi  mental design in a number of 
cited behavioral studies. However, our aim 
was to identify and review the mecha  nisms 
under  lying the observed adverse (behavioral) 
effects, not to evaluate the experimental 
design of behavioral studies within a regula-
tory setting. Nonetheless, approximately 10% 
of our review was dedicated to describing a 
number of behavioral studies [12 different 
studies from seven different research groups, 
including a 2008 EPA study (Gee and Moser 
2008)] that all indicated the occurrence of 
neuro  behavioral effects following develop-
mental exposure to PBDEs. We used this 
information to create a starting point for the 
main part of our review of direct and indirect 
cellular and molecular mechanisms. For read-
ability and space limitations, we were not 
able to include all studies, concerns, or cri-
tiques that have ever been raised. The absence 
of a citation to a particular study does not 
mean that we regard it as less credible.
The view that (developmental) exposure 
to PBDEs induces adverse neuro  toxic effects 
is widely supported by numerous in vivo, 
ex vivo, and in vitro studies reporting both 
structural and functional effects (Dingemans 
et al. 2011). For some time, a lively discus-
sion has been taking place within the scien-
tific community on the experimental design 
for behavioral developmental neuro  toxicity 
studies for regulatory purposes, in particular 
considering the statistical unit (Alcock et al. 
2011). In short, there is disagreement about 
whether direct dosing of pups precludes 
the need to control for litter effects (e.g., 
Eriksson 2008; Hardy and Stedeford 2008). 
However, we did not address this topic in 
our paper because we consider the potential 
occurrence of a litter effect to be irrele  vant for 
the reviewed cellular and molecular in vitro 
studies, which all indicate that exposure to 
PBDEs induces neurotoxic effects.
Critical remarks can be found through-
out our review (Dingemans et al. 2011), but 
they are related to cellu  lar and molecular 
findings, data gaps, or aspects that warrant 
further investigation. Our main conclusions 
are related to the specific (developmental) 
neuro  toxic hazard of OH-PBDEs compared 
with that of their parent congeners via direct 
neuro  toxicity and thyroid disruption. We also 
pointed out the need to further investigate the 
impact of active metabolites, concentrations 
of PBDEs and metabolites in the (developing) 
brain, and the potentially increased neuro-
toxic hazard following exposure to mixtures 
of different environmental contaminants.
Nonetheless, Banasik and Suchecka raise 
an important issue: the existence of differences 
in experimental designs for in vivo investi-
gation of (developmental) neuro  toxicity. 
Differences exist in the selection of investi-
gated end points and also in methodologies 
for the investigation of a specific end point, 
as reviewed for effects on motor activity by 
brominated flame retardants (Williams and 
DeSesso 2010). These differences in experi-